Targeted Therapies in Epithelial Ovarian Cancer
Molecularly targeted therapy is relatively new to ovarian cancer despite the unquestionable success with these agents in other solid tumours such as breast and colorectal cancer. Advanced ovarian cancer is chemosensitive and patients can survive several years on treatment. However chemotherapy dimin...
Main Authors: | Jurjees Hasan, Loaie El-Helw, Emma Dean |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/2/1/88/ |
Similar Items
-
Targeting Signaling Pathways in Epithelial Ovarian Cancer
by: Johannes Haybaeck, et al.
Published: (2013-05-01) -
Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer
by: Luyao Guan, et al.
Published: (2020-03-01) -
Epithelial ovarian cancer: Review article
by: Suchetha Sambasivan
Published: (2022-01-01) -
Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment
by: Clare eScott, et al.
Published: (2013-12-01) -
Ovarian Cancer Targeted Theranostics
by: Sridhar Nimmagadda, et al.
Published: (2020-01-01)